Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis
Author:
Funder
AbbVie
Almirall
Amgen
AnaptysBio
Asana Biosciences
Boehringer Ingelheim
Celgene
Dermavant
DS Biopharma
Eli Lilly
Galderma
Ichnos Sciences
Innovaderm
Janssen
Kiniska
Kyowa Kirin
Leo Pharma
Novan
Pfizer
Ralexar
Regeneron
Sienna Biopharma
UCB
Union Therapeutics
Publisher
Elsevier BV
Subject
Dermatology
Reference46 articles.
1. Epidemiology of atopic dermatitis in adults: results from an international survey;Barbarot;Allergy,2018
2. Targeting key proximal drivers of type 2 inflammation in disease;Gandhi;Nat Rev Drug Discov,2016
3. Dupilumab for treatment of atopic dermatitis;Seegraber;Expert Rev Clin Pharmacol,2018
4. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis;Beck;N Engl J Med,2014
5. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial;Thaci;Lancet,2016
Cited by 141 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Podcast on Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases;Dermatology and Therapy;2024-02-03
2. [Artículo traducido]Eficacia y seguridad de dupilumab para el tratamiento de la dermatitis atópica grave en la práctica clínica: experiencia en un centro terciario;Actas Dermo-Sifiliográficas;2024-02
3. Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience;Actas Dermo-Sifiliográficas;2024-02
4. Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most;Journal of Dermatological Treatment;2024-01-31
5. Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study;Children;2024-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3